Not admitted · Not a forecast
Rules 1.1.0 · as of 14 Sep 2026
Owen Scott Muir · Said 4 Nov 2025 · owen-1943
Quote
Not a forecast
“Personally, I suspect that in the right patients, Spravato and ketamine are both effective, and an underpowered study isn’t changing my perspective too much.”
The author rejects the implication of the negative KARMA-Dep 2 trial (ketamine vs. midazolam) and expects ketamine and Spravato efficacy to hold up in appropriately selected patients as further evidence accrues.
Descriptive, retrospective, or a statement of preference; no future state asserted.